BIO-key International Enters into $3.1 Million Warrant Inducement Transaction

Core Insights - BIO-key International, Inc. has entered into a warrant inducement agreement with an institutional investor to exercise outstanding warrants, resulting in the purchase of 3,091,668 shares at a reduced price of $1.02 per share, generating approximately $3.1 million in gross proceeds [1][3] Group 1: Warrant Inducement Agreement - The investor will exercise Series A and Series B Warrants to purchase 3,091,668 shares at $1.02 per share [1] - In exchange, the company will issue unregistered New Warrants for 6,183,336 shares at the same exercise price of $1.02, which are immediately exercisable and expire in five years [3] - The company plans to file a registration statement with the SEC for the resale of shares from the New Warrants [3] Group 2: Company Overview - BIO-key is focused on biometric authentication and Identity and Access Management (IAM) solutions, securing access for over 40 million users [4] - The company offers various authentication methods, including phoneless, tokenless, and passwordless options, through its PortalGuard IAM solution [4]